Zhou Angela L, Raj Suseela, Fedorova Ekaterina, Garonzik-Wang Jacqueline, Mandelbrot Didier, Astor Brad C, Parajuli Sandesh
Division of Nephrology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Division of Transplant Surgery, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Clin Transplant. 2025 Jun;39(6):e70199. doi: 10.1111/ctr.70199.
Kidney-delayed graft function (DGF) is more common in donation after circulatory death (DCD) donors in comparison to donatation after brain death (DBD). We analyzed deceased kidney transplant recipients (DDKTR) at our center between 2005 and 2019, stratified by donor type (DBD vs. DCD).
We assessed risk factors for DGF, acute rejection (AR), graft failure (GF), along with the death with functioning graft (DWFG), and the interaction between types of donors for those complications.
Among 2543 DDKTRs, 804 (32%) were from DCD donors. Older donor age, higher recipient body mass index, and receipt of a depleting induction agent were associated with increased risk for DGF in both DBD and DCD. In contrast, preemptive transplant and female recipient gender were associated with reduced risk. Additional risk factors in DBD, but not in DCD recipients, included higher donor terminal serum creatinine, higher kidney donor profile index, right donor kidney, and prolonged cold ischemia time. Female donors were associated with a reduced risk of DGF only among DCD donors. DGF was associated with higher AR and GF, with no significant differences across donor types, DBD vs. DCD (AR: adjusted hazard ratio [aHR] 2.22 vs. 2.37, p-interaction = 0.65; GF: 3.04 vs. 2.56; p-interaction = 0.47). DGF was associated with a higher risk for DWFG among DBD (aHR: 3.43, 95% CI: 1.96-6.00, p < 0.001) but not with DCD (aHR: 1.90, 95% CI: 0.78-4.61, p = 0.16), with p-interaction of 0.15 CONCLUSION: Despite higher DGF rates in DCD, early adverse outcomes after DGF were similar between deceased donor types and should not deter the utilization of DCD kidneys.
与脑死亡后捐赠(DBD)相比,肾延迟移植功能(DGF)在心脏死亡后捐赠(DCD)供体中更为常见。我们分析了2005年至2019年期间在我们中心的已故肾移植受者(DDKTR),并按供体类型(DBD与DCD)进行分层。
我们评估了DGF、急性排斥反应(AR)、移植失败(GF)的危险因素,以及移植肾功能正常时的死亡(DWFG),并分析了这些并发症在不同供体类型之间的相互作用。
在2543例DDKTR中,804例(32%)来自DCD供体。供体年龄较大、受者体重指数较高以及接受耗竭性诱导剂与DBD和DCD中DGF风险增加相关。相比之下,抢先移植和女性受者性别与风险降低相关。DBD受者而非DCD受者的其他危险因素包括供体终末期血清肌酐较高、肾脏供体概况指数较高、右供体肾以及冷缺血时间延长。女性供体仅在DCD供体中与DGF风险降低相关。DGF与较高的AR和GF相关,不同供体类型(DBD与DCD)之间无显著差异(AR:调整后风险比[aHR]2.22对2.37,p相互作用=0.65;GF:3.04对2.56;p相互作用=0.47)。DGF与DBD中DWFG的较高风险相关(aHR:3.43,95%CI:1.96 - 6.00,p < 0.001),但与DCD无关(aHR:1.90,95%CI:0.78 - 4.61,p = 0.16),p相互作用为0.15。结论:尽管DCD中DGF发生率较高,但不同已故供体类型中DGF后的早期不良结局相似,不应妨碍使用DCD肾脏。